Diabetic ketoacidosis in a case of pheochromocytoma. 2001

C Ishii, and K lnoue, and K Negishi, and N Tane, and T Awata, and S Katayama
The Fourth Department of Medicine, Saitama Medical School, 38 Morohongo, Moroyama-Machi, Saitama 350-0495, Iruma-Gun, Japan. cishii-nsh@umin.ac.jp

A 31-year-old woman was admitted to our hospital because of diabetic ketoacidosis (DKA). Ultrasound sonography revealed the existence of the left adrenal tumor and endocrinological examinations established a diagnosis of pheochromocytoma. She had been healthy and there was no evidence for gestational diabetes in her personal history. Characteristic features were not found in her tumor size and the catecholamine levels as compared with typical cases of pheochromocytoma. An overwhelming secretion of catecholamine might suppress insulin secretion, as evidenced by the improvement after the resection of the tumor. However, a significant insulin resistance continued after tumor resection. Obesity and the heterozygosity of beta3-adrenergic receptor gene (Try64Arg) might play a role in insulin resistance, which resulted in DKA at least in part. Literature survey revealed four cases of DKA in the patients with pheochromocytoma including ours, three of which were Japanese. Pancreatic capacity to secrete insulin has been reported to be less than Caucasians, which might be another reason for DKA. Thus, we speculate that both suppressed insulin secretion and insulin resistance deteriorated by obesity or other factor(s) such as abnormality in beta3 adrenergic receptor probably depress beta-cell function resulting in abnormal metabolic imbalance such as DKA.

UI MeSH Term Description Entries
D010673 Pheochromocytoma A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298) Pheochromocytoma, Extra-Adrenal,Extra-Adrenal Pheochromocytoma,Extra-Adrenal Pheochromocytomas,Pheochromocytoma, Extra Adrenal,Pheochromocytomas,Pheochromocytomas, Extra-Adrenal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000310 Adrenal Gland Neoplasms Tumors or cancer of the ADRENAL GLANDS. Adrenal Cancer,Adrenal Gland Cancer,Adrenal Neoplasm,Cancer of the Adrenal Gland,Neoplasms, Adrenal Gland,Adrenal Cancers,Adrenal Gland Cancers,Adrenal Gland Neoplasm,Adrenal Neoplasms,Cancer, Adrenal,Cancer, Adrenal Gland,Cancers, Adrenal,Cancers, Adrenal Gland,Neoplasm, Adrenal,Neoplasm, Adrenal Gland,Neoplasms, Adrenal
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016883 Diabetic Ketoacidosis A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA. Acidosis, Diabetic,DKA Diabetic Ketoacidosis,Diabetic Acidosis,Diabetic Ketosis,Ketoacidosis, Diabetic,Ketosis, Diabetic,Acidoses, Diabetic,DKA Diabetic Ketoacidoses,Diabetic Acidoses,Diabetic Ketoacidoses,Diabetic Ketoacidosis, DKA,Diabetic Ketoses,Ketoacidoses, Diabetic,Ketoacidosis, DKA Diabetic,Ketoses, Diabetic
D020738 Leptin A 16-kDa peptide hormone secreted from WHITE ADIPOCYTES. Leptin serves as a feedback signal from fat cells to the CENTRAL NERVOUS SYSTEM in regulation of food intake, energy balance, and fat storage. Ob Protein,Obese Protein,Ob Gene Product,Obese Gene Product,Gene Product, Ob,Gene Product, Obese

Related Publications

C Ishii, and K lnoue, and K Negishi, and N Tane, and T Awata, and S Katayama
November 1996, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
C Ishii, and K lnoue, and K Negishi, and N Tane, and T Awata, and S Katayama
October 2016, BMJ case reports,
C Ishii, and K lnoue, and K Negishi, and N Tane, and T Awata, and S Katayama
January 2008, Journal of diabetes and its complications,
C Ishii, and K lnoue, and K Negishi, and N Tane, and T Awata, and S Katayama
January 2016, Journal of investigative medicine high impact case reports,
C Ishii, and K lnoue, and K Negishi, and N Tane, and T Awata, and S Katayama
January 1992, Cleveland Clinic journal of medicine,
C Ishii, and K lnoue, and K Negishi, and N Tane, and T Awata, and S Katayama
December 2000, Medicina clinica,
C Ishii, and K lnoue, and K Negishi, and N Tane, and T Awata, and S Katayama
September 1996, Diabetes research and clinical practice,
C Ishii, and K lnoue, and K Negishi, and N Tane, and T Awata, and S Katayama
March 2012, Journal of clinical research in pediatric endocrinology,
C Ishii, and K lnoue, and K Negishi, and N Tane, and T Awata, and S Katayama
November 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
C Ishii, and K lnoue, and K Negishi, and N Tane, and T Awata, and S Katayama
October 2001, Diabetic medicine : a journal of the British Diabetic Association,
Copied contents to your clipboard!